Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.

Saved in:
Bibliographic Details
Title: Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.
Authors: Sanchis-Borja M; Pulmonology Department, Créteil Intercommunal Hospital, Créteil, France., Guisier F; Normandie Univ, UNIROUEN, LITIS Laboratory QuantIF team EA4108, CHU Rouen, Department of Pneumology and Inserm CIC-CRB 1404, Rouen, France., Swalduz A; Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France., Curcio H; Department of Medical Oncology, Centre François Baclesse, Caen, France., Basse V; Centre Oncologie Saint Yves, Vannes, France., Maritaz C; Medical Affairs Department, Oncology, Boehringer Ingelheim France, Paris, France., Chouaid C; Pulmonology Department, Créteil Intercommunal Hospital, Créteil, France., Auliac JB; Pulmonology Department, Créteil Intercommunal Hospital, Créteil, France.
Source: OncoTargets and therapy [Onco Targets Ther] 2024 May 29; Vol. 17, pp. 439-448. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101514322 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6930 (Print) Linking ISSN: 11786930 NLM ISO Abbreviation: Onco Targets Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1178-6930
DOI:10.2147/OTT.S448909